These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7583385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D.
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K, Kekomäki R, Ruutu T, Koskimies S, Myllylä G.
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ, Schiffer CA.
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia.
    Oksanen K.
    Eur J Haematol; 1994 Aug; 53(2):100-7. PubMed ID: 8088380
    [Abstract] [Full Text] [Related]

  • 13. A specific assay for anti-HLA antibodies: application to platelet donor selection.
    Millard FE, Tani P, McMillan R.
    Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
    [Abstract] [Full Text] [Related]

  • 14. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL, Makuch R, Appelbaum F, Ungerleider RS, Abrams R, O'Donnell J, Holohan TV, Fontana J, Wright D, Anagnou NP.
    Cancer; 1988 Aug 15; 62(4):795-801. PubMed ID: 3293762
    [Abstract] [Full Text] [Related]

  • 15. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
    Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH.
    Transfusion; 1996 Apr 15; 36(4):296-302. PubMed ID: 8623127
    [Abstract] [Full Text] [Related]

  • 16. Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.
    Hu X, Cai H, Zheng L, Luo Y, Zhou J, Hui Y, Dai Z, Lin H, Li D, Xiao Y, Huang L, Zhou J.
    Cancer Med; 2020 Jul 15; 9(14):4941-4948. PubMed ID: 32419364
    [Abstract] [Full Text] [Related]

  • 17. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.
    Comont T, Tavitian S, Bardiaux L, Fort M, Debiol B, Morère D, Bérard E, Delabesse E, Luquet I, Martinez S, Huguet F, Récher C, Bertoli S.
    Leuk Res; 2017 Oct 15; 61():62-67. PubMed ID: 28910610
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness of etoposide on reactive histiocytosis and refractory state to platelet transfusion during therapy of leukemia: case report].
    Ishida Y, Yokota Y, Tauchi H, Matusda H.
    Rinsho Ketsueki; 1991 Sep 15; 32(9):970-5. PubMed ID: 1942543
    [Abstract] [Full Text] [Related]

  • 19. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer.
    Saarinen UM, Koskimies S, Myllylä G.
    Vox Sang; 1993 Sep 15; 65(4):286-92. PubMed ID: 8310680
    [Abstract] [Full Text] [Related]

  • 20. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG, Brand A.
    Exp Hematol; 1981 Jan 15; 9(1):77-83. PubMed ID: 7238644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.